Research Article

Microtransesophageal Echocardiographic Guidance during Percutaneous Interatrial Septal Closure without General Anaesthesia

Table 2

In-hospital follow-up data after percutaneous ASD and PFO closure using TEE and micro-TEE.

ASDPFO
TEEMicro-TEETEEMicro-TEE

Number, n46365565
Device diameter (mm)26 (10–40)27 (10–35)25 (23–35)27 (23–35)
Complications, n (%)
SVT0 (0%)1 (2.8%)0 (0%)2 (3.1%)
Device embolism0 (0%)0 (0%)0 (0%)0 (0%)
Bleeding no transfusion0 (0%)0 (0%)0 (0%)0 (0%)
Pericardial effusion1 (2.2%)0 (0%)1 (1.8%)0 (0%)
TTE, n46 (100%)36 (100%)55 (100%)65 (100%)
RLS, n (%)
No shunt20 (36.4%)53 (81.5%)
Minimal26 (47.3%)8 (12.3%)
Moderate4 (7.3%)2 (3.1%)
Severe5 (9.1%)2 (3.1%)
LRS, n (%)11 (24%)3 (8.3%)

Data are presented as median (range); ASD, atrial septal defect; PFO, patent foramen ovale; TEE, transesophageal echocardiography; SVT, supraventricular tachycardia; TTE, transthoracic echocardiography; RLS, right-to-left shunt; LRS, left-to-right shunt.